Effects of Olmesartan, an Angiotensin II Receptor Blocker, on Peripheral Insulin Sensitivity in Japanese Subjects with Type 2 Diabetes and Hypertension-Reference-Cited by-同舟云学术

Effects of Olmesartan, an Angiotensin II Receptor Blocker, on Peripheral Insulin Sensitivity in Japanese Subjects with Type 2 Diabetes and Hypertension

Published:2012 Issue:16 Volume:51 Page:2091-2096
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Shimoda Seiya¹,Goto Rieko¹,Furukawa Noboru¹,Tsuruzoe Kaku¹,Kawashima Junji¹,Iwashita Shinsuke¹,Maeda Takako¹,Ichimori Shinji²,Ichinose Kenshi¹,Nishida Kenro³,Araki Eiichi¹

Affiliation:

1. Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan

2. Ueki Hospital, Japan

3. Minamata City Hospital and Medical Center, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/51/16/51_51.7408/_pdf

Reference33 articles.

1. 1. Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353: 611-616, 1999.

2. 2. McMurray JJ, Holman RR, Haffner SM, et al; Navigator Study Group. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 362: 1477-1490, 2010.

3. 3. Uehara M, Kishikawa H, Isami S, et al. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 37: 300-307, 1994.

4. 4. Isami S, Kishikawa H, Araki E, et al. Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway. Diabetologia 39: 412-420, 1996.

5. 5. Motoshima H, Araki E, Nishiyama T, et al. Bradykinin enhances insulin receptor tyrosine kinase in 32D cells reconstituted with bradykinin and insulin signaling pathways. Diabetes Res Clin Pract 48: 155-170, 2000.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): “Issues with hypertension studies in real-world practice”;Clinical and Experimental Hypertension;2019-11-22

2. Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension;Hypertension Research;2015-02-12

3. Effects of beraprost sodium, an oral prostacyclin analog, on insulin resistance in patients with type 2 diabetes;Diabetology International;2014-04-18

4. RETRACTED: Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies;Journal of the American Society of Hypertension;2013-01